The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Congestive Heart Failure Treatment Devices Market Projected To Become By 2030 Based On Its 2026 Valuation?
The congestive heart failure treatment devices market has experienced substantial expansion in its size over recent years. Projections indicate a rise from $21.07 billion in 2025 to $22.76 billion in 2026, with a compound annual growth rate (CAGR) of 8.0%. This past growth is attributable to several key elements, such as the increasing prevalence of congestive heart failure, a greater incidence of cardiovascular diseases, the growing adoption of implantable cardiac devices, the expansion of specialized cardiac care facilities, and improved survival rates for heart failure patients.
The congestive heart failure treatment devices market size is anticipated to experience robust growth over the coming years, with projections indicating it will reach $30.07 billion in 2030, driven by a compound annual growth rate (CAGR) of 7.2%. This expansion during the forecast period is largely attributable to an aging population facing a higher risk of heart failure, increasing demand for minimally invasive cardiac therapies, a growing focus on early intervention and disease management, expanding access to advanced heart failure treatment in emerging markets, and the rising adoption of long-term mechanical circulatory support devices. Significant trends for this period include the increasing uptake of advanced implantable heart failure devices, the expanded use of ventricular assist devices in advanced congestive heart failure, a heightened emphasis on reducing heart failure hospitalizations, the broadening of device-based therapies for long-term heart support, and an increasing need for continuous cardiac monitoring and management.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15774&type=smp
What Primary Drivers Are Shaping The Development Of The Congestive Heart Failure Treatment Devices Market?
The increasing occurrence of cardiovascular disorders is projected to fuel the expansion of the congestive heart failure treatment devices market. These disorders encompass a range of conditions affecting the heart and blood vessels, including coronary artery disease, hypertension, and heart failure, thereby influencing blood circulation and overall cardiac well-being. The growing incidence of cardiovascular disorders primarily stems from an uptick in risk factors such as obesity, inactive lifestyles, unhealthy diets, and an aging demographic. Congestive heart failure treatment devices play a vital role in addressing cardiovascular disorders by stabilizing heart rhythms and enhancing cardiac function, leading to significantly better patient results. For example, data from October 2024, provided by the US-based government agency, the Centers for Disease Control and Prevention, showed that in 2023, cardiovascular disease was responsible for 919,032 deaths, representing one in every three fatalities. Coronary heart disease remained the most common type of heart disease, with approximately one in six cardiovascular disease deaths occurring in individuals younger than 65 years old. Consequently, the rising prevalence of cardiovascular disorders is a key driver for the growth of the congestive heart failure (CHF) treatment devices market.
What Segment Groups Are Identified Within The Congestive Heart Failure Treatment Devices Market?
The congestive heart failure treatment devices market covered in this report is segmented –
1) By Product: Cardiac Pacemaker, Implantable Cardioverter Defibrillators (ICDs), Cardiac Resynchronization Therapy Devices (CRT), Counter Pulsation Devices, Ventricular Assist Devices (VADs)
2) By Application: Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BIVAD)
3) By End-User: Hospitals And Clinic, Specialized Cardiovascular Disease Treatment Centers, Ambulatory Surgery Centers
Subsegments:
1) By Cardiac Pacemaker: Single Chamber Pacemaker, Dual Chamber Pacemaker, Biventricular Pacemaker
2) By Implantable Cardioverter Defibrillators (ICDs): Traditional ICDs, Subcutaneous ICDs, CRT-D (Cardiac Resynchronization Therapy Defibrillator)
3) By Cardiac Resynchronization Therapy Devices (CRT): CRT-P (Cardiac Resynchronization Therapy Pacemaker), CRT-D (Cardiac Resynchronization Therapy Defibrillator)
4) By Counter Pulsation Devices: Intra-Aortic Balloon Pumps (IABP), External Counterpulsation Devices (ECP)
5) By Ventricular Assist Devices (VADs): Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), Biventricular Assist Devices (BiVAD)
What Trends Are Advancing Progress In The Congestive Heart Failure Treatment Devices Market?
Major companies in the congestive heart failure treatment devices market are focusing on developing advanced solutions like the implant-free atrial septostomy system to improve hemodynamic relief, reduce procedural complexity, and provide less invasive treatment options for heart failure patients. An implant-free atrial septostomy system is a minimally invasive device designed to create a controlled opening in the atrial septum without leaving a permanent implant, which allows for better left atrial pressure reduction and enhanced cardiac hemodynamics in heart failure patients. For example, in January 2025, Alleviant Medical Inc., a US-based medical device company, reached significant FDA milestones for its innovative no-implant interatrial shunt device for treating heart failure. This device offers a minimally invasive solution for heart failure by creating a precise shunt that lowers elevated pressure in the left atrium without leaving a permanent implant. This approach minimizes complications associated with implanted devices, promotes lasting shunt patency, and improves symptoms, exercise capacity, and quality of life for chronic heart failure patients. Its purpose is to unload the heart, alleviate symptoms, and provide a safer, innovative treatment choice for patients with limited alternatives.
Which Companies Hold Significant Positions In The Congestive Heart Failure Treatment Devices Market?
Major companies operating in the congestive heart failure treatment devices market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co KG, LivaNova PLC, Berlin Heart GmbH, Jarvik Heart Inc, ReliantHeart Inc, Abiomed Inc, Lepu Medical Technology Co Ltd, Magenta Medical Ltd, MicroPort Inc, EBR Systems Inc, Syncardia Systems LLC, Oscor Inc, OSYPKA Medical GmbH, Calon Cardio-Technology, CoreWave SA, Zoll Medical Corporation
Read the full congestive heart failure treatment devices market report here:
How Does The Congestive Heart Failure Treatment Devices Market Perform Across Major Global Regions?
North America was the largest region in the congestive heart failure treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congestive heart failure treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Congestive Heart Failure Treatment Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15774&type=smp
Browse Through More Reports Similar to the Global Congestive Heart Failure Treatment Devices Market 2026, By The Business Research Company
Heart Defect Closure Device Market Report 2026
https://www.thebusinessresearchcompany.com/report/heart-defect-closure-device-global-market-report
Congestive Heart Failure Treatment Devices Market Report 2026
Structural Heart Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model